Spectropolarimetry in the differential diagnosis of benign and malignant ovarian tumors

被引:0
|
作者
Peresunko, O. P. [1 ]
Yermolenko, S. B. [2 ]
Gruia, I. [3 ]
机构
[1] Bukovinian State Med Univ, 2 Theatre Sq, UA-58000 Chernovtsy, Ukraine
[2] Chernivtsi Natl Univ, 2 Kotsyubinsky Str, UA-58012 Chernovtsy, Ukraine
[3] Univ Bucharest, Fac Phys, Bucharest, Romania
关键词
polarimetry; spectrometry; blood plasma; ovarian cancer; CONTINUOUS LASER-RADIATION; DIFFRACTION; WATER;
D O I
10.1117/12.2303946
中图分类号
O43 [光学];
学科分类号
070207 ; 0803 ;
摘要
The aim of this study was to use the spectrophotometry method to develop a diagnostic algorithm for blood studies and the content of douglas deepening in women with ovarian tumors. A comparative analysis of the blood of healthy women and patients with ovarian cancer revealed significantly greater optical anisotropy of the latter. Qualitative studies of polarization microscopic blood images revealed a very developed microcrystalline structure. Based on the study of blood and puncture and douglas deepening of healthy women and patients with benign and malignant tumors of the ovaries, using the method of laser polarimetry, experimentally developed and clinically tested photometric and polarization criteria indicating the presence of malignancy of the tumor.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Contrast-Enhanced Ultrasonography in Differential Diagnosis of Benign and Malignant Ovarian Tumors
    Qiao, Jing-Jing
    Yu, Jing
    Yu, Zhe
    Li, Na
    Song, Chen
    Li, Man
    PLOS ONE, 2015, 10 (03):
  • [2] Clinical evaluation of MRI in the differential diagnosis between benign and malignant ovarian tumors
    Zhang, Tao
    Yi, Xin
    Lu, Jian
    Fu, Aiyan
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (02) : 257 - 262
  • [3] DIFFERENTIAL DIAGNOSIS OF BENIGN AND MALIGNANT BREAST TUMORS
    LEIS, HP
    GERIATRICS, 1967, 22 (01) : 181 - &
  • [4] Assessment of protein biomarkers for preoperative differential diagnosis between benign and malignant ovarian tumors
    Landolfo, C.
    Achten, E. T. L.
    Ceusters, J.
    Baert, T.
    Froyman, W.
    Heremans, R.
    Vanderstichele, A.
    Thirion, G.
    Van Hoylandt, A.
    Claes, S.
    Oosterlynck, J.
    Van Rompuy, A. S.
    Schols, D.
    Billen, J.
    Van Calster, B.
    Bourne, T.
    Van Gorp, T.
    Vergote, I.
    Timmerman, D.
    Coosemans, A.
    GYNECOLOGIC ONCOLOGY, 2020, 159 (03) : 811 - 819
  • [5] Systematic review and meta-analysis of imaging differential diagnosis of benign and malignant ovarian tumors
    Wang, Wen-Huan
    Zheng, Chang-Bao
    Gao, Jin-Niao
    Ren, Shang-Shang
    Nie, Guo-Yan
    Li, Zhi-Qun
    GLAND SURGERY, 2022, 11 (02) : 330 - 340
  • [6] Clinical review on the differential diagnosis of benign and malignant ovarian cancer
    Ismailova, Munojat
    Nigmatjonov, Abdurashid
    Usmanova, Zilola
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2020, 11 : 306 - 308
  • [7] Salient magnetic resonance imaging findings in the differential diagnosis of benign, borderline and malignant ovarian mucinous tumors
    Ozyilmaz, Safa
    Kulali, Fatma
    Topal, Cumhur Selcuk
    Yalcinkaya, Cem
    ABDOMINAL RADIOLOGY, 2025, 50 (02) : 1009 - 1017
  • [8] Peritoneal fluid cytokines and the differential diagnosis of benign and malignant ovarian tumors and residual/recurrent disease examination
    Chechlinska, M.
    Kaminska, J.
    Markowska, J.
    Kramar, A.
    Steffen, J.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2007, 22 (03): : 172 - 180
  • [9] Peritoneal fluid cytokine evaluation for differential diagnosis of benign and malignant ovarian tumors and for disease eradication assessment
    Magdalena, Chechlinska
    Steffen, J.
    TUMOR BIOLOGY, 2006, 27 : 6 - 6
  • [10] BORDERLINE OVARIAN TUMORS - ARE THEY BENIGN OR MALIGNANT?
    Lazarou, Anastasia
    Fotopoulou, Christina
    Coumbos, Alexandra
    Sehouli, Jalid
    Vasiljeva, Jekaterina
    Braicu, Ioana
    Burger, Heinz
    Kuehn, Wolfgang
    ANTICANCER RESEARCH, 2014, 34 (10) : 6257 - 6257